Anti-Human TNFα (Adalimumab Biosimilar)
英诺赛图(InnoCyto)的 Anti-Human TNFα (Adalimumab Biosimilar)(克隆 Adalimumab) 为人源 IgG1 抗体,靶向 TNFα。提供 1 mg、5 mg、20 mg 规格,目录价 ¥1,288 起,仅供科研使用(RUO)。
01产品图片

02产品简介
英诺赛图(InnoCyto)的 Anti-Human TNFα (Adalimumab Biosimilar)(克隆 Adalimumab) 为人源 IgG1 抗体,靶向 TNFα。提供 1 mg、5 mg、20 mg 规格,目录价 ¥1,288 起,仅供科研使用(RUO)。
03产品介绍
规格与货号
500301 | 1 mg | ¥1,288
500302 | 5 mg | ¥4,000
500303 | 20 mg | ¥12,204
Product Details
Application|Neutralization, Intracellular Flow cytometry, animal model study
Product Description|Anti-Human TNFα (Adalimumab Biosimilar)
Regulatory Status|RUO
Species specificity|Human
Min Sample Size|1 mg
Storage Conditions|4ºC
Maximal Shelf Life|12 months
See All Formats|Clone Adalimumab
Background Information
Adalimumab is a fully human monoclonal antibody that belongs to the immunoglobulin G1 (IgG1) subclass. It was developed using recombinant DNA technology in mammalian cell expression systems, such as Chinese Hamster Ovary (CHO) cells, to ensure proper protein folding, glycosylation, and functional integrity. Structurally, Adalimumab is a 148-kilodalton (kDa) glycoprotein composed of two identical heavy chains and two identical light chains connected by disulfide bonds, resulting in a typical Y-shaped antibody configuration. Each heavy chain consists of variable and constant regions, including CH1, CH2, and CH3 domains, while each light chain contains one variable and one constant domain. The molecule contains N-linked glycosylation sites in the Fc region, which contribute to stability, solubility, and interactions with immune effectors.
The functional activity of Adalimumab derives from its high-affinity binding to tumor necrosis factor-alpha (TNF-α), a proinflammatory cytokine involved in immune signaling and regulation. Each Fab fragment of Adalimumab contains complementarity-determining regions (CDRs) that specifically recognize and bind to soluble and transmembrane forms of human TNF-α with nanomolar affinity. By binding tightly to TNF-α, the antibody prevents the cytokine from interacting with its cellular receptors, TNFR1 (p55) and TNFR2 (p75), effectively blocking downstream signaling pathways that lead to the expression of inflammatory mediators, adhesion molecules, and other immune-regulatory proteins.
In addition to its antigen-binding capacity, Adalimumab’s Fc region mediates secondary molecular interactions important for immune modulation. These include binding to neonatal Fc receptors (FcRn), which extend the antibody’s circulatory half-life by protecting it from lysosomal degradation, and engagement with Fc gamma receptors (FcγRs), though Adalimumab is engineered to minimize undesired effector functions such as complement activation. Overall, Adalimumab represents a well-characterized biologic molecule whose precise molecular architecture enables high target specificity, structural stability, and controlled immunomodulatory function in research applications studying cytokine signaling and immune regulation.
Data Sheets
Cat # Size Price Quantity 5003011 mg Add to Cart5003025 mg Add to Cart50030320 mg Add to Cart
04完整参数表
参数由厂商资料整理,采购前请以最终报价单与技术协议为准。
05荣誉与资质
该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。
- 营业执照未上传
- 品牌授权未上传
- 产品检测报告未上传
- 会员身份
- 收费会员
- 经营身份
- 原厂
- 成立年份
- 2020 年
- 所在地
- 上海
- 收录条目
- 1865 个
- 平台核验
- 平台代管
06品牌与供应商
InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。
品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。
07同类条目
同一子类内的条目才具备可比性。跨子类比较参数通常没有意义。
08同品牌其他条目
上海英诺赛图 在本目录共 1865 个条目,除本条外还有:
科研在线(TeleVM). Anti-Human TNFα (Adalimumab Biosimilar)(500301)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/anti-human-tnf-adalimumab-biosimilar.html.
TeleVM. (2026, November 12). Anti-Human TNFα (Adalimumab Biosimilar)(500301). 产品目录. https://www.suprotek.cn/products/item/anti-human-tnf-adalimumab-biosimilar.html
@misc{biocsp_item_anti_human_tnf_adalimumab_biosimilar,
title = {Anti-Human TNFα (Adalimumab Biosimilar)(500301)},
author = {{科研在线}},
year = {2026},
howpublished = {产品目录},
note = {更新于 2026-11-12,产品目录},
url = {https://www.suprotek.cn/products/item/anti-human-tnf-adalimumab-biosimilar.html}
}
GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。
许可:CC BY-NC 4.0 · 转载注明来源